UiPath Analysts Raise Targets After Worst Week in 4 Months
Multiple analysts raised UiPath price targets despite the stock's worst weekly decline in four months, but persistent skepticism about concrete AI monetization keeps PATH rangebound until the next ear
UiPath Analysts Raise Targets After Worst Week in 4 Months
NEW YORK, September 14 —
UiPath, Inc. (PATH) closed its worst week in four months at $14.72 while multiple analysts raised price targets anyway, a contradiction that maps the stock's situation precisely.
- PATH recorded its worst weekly decline in four months, closing at $14.72, even as multiple analysts lifted price targets following the selloff
- $474mn annual FCF on $1.7bn TTM revenue implies a 27.9% free cash flow margin; the stock trades at just 16x forward earnings on 13.4% YoY growth
- AI-attributed ARR as a standalone disclosure is the specific metric analysts named; the next earnings call is when this story either breaks open or stalls
25.6% Short Float Turns Any AI Beat Into a Squeeze, Not Just a Re-Rate
More than a quarter of PATH's float is sold short. That is not purely a bearish signal; it is a leverage mechanism. When a stock carrying that level of short interest gets a genuine catalyst, covering pressure amplifies any fundamental re-rating considerably. If next quarter's earnings call surfaces a standalone AI-attributed ARR figure or a named enterprise contract tied to agentic document automation, the move is not incremental. The bull thesis here is not just "AI earns revenue." It is "AI earns revenue and 25.6% of the float has to buy back in." That is a different kind of upside.
$474mn Free Cash Flow Is the Quality Floor Bears Are Pricing Past
PATH converts nearly 28 cents of every revenue dollar into free cash flow. Most software companies growing at 13.4% YoY cannot hold that margin. At $14.72 with $0.67 in trailing EPS and a 16x forward P/E, the market is pricing stagnation, not a business generating $474mn annually in FCF. The shorts are not wrong about slowing growth. They may be wrong about what the valuation floor looks like when a high-FCF business is also sitting on an unmonetized AI capability. That is the discrepancy the upgrades are flagging, even if they cannot close it without a number to point to.
Document Intelligence Already Has an Enterprise Budget Line, Not Just a Roadmap
UiPath leads in extracting structured data from unstructured documents, a capability that enterprise IT buyers have active 2026 budget for, not a speculative item. Wire coverage frames this as an AI potential story. The more precise read is whether the market will credit UiPath for AI revenue it may already be generating via document automation, or continue classifying it as legacy RPA momentum with an AI label attached. The upgrade thesis lives in that gap between what the business does and how the market accounts for it.
One Number at the Next Earnings Call Closes the Stalemate
Analysts have named a single requirement: AI-attributed ARR as a standalone line, not embedded in a bookings percentage or described in narrative terms. Without it, 25.6% short interest stays anchored, the 16x forward multiple stays compressed, and the target raises remain polite positioning rather than actionable catalysts. Produce that number and this setup changes quickly. Miss it, and PATH tests a new 4-month low. At that level with $1.7bn in TTM revenue and that FCF run rate, the gap between fundamental quality and market pricing is real, but it does not close on goodwill.
For PATH's full fundamental breakdown and valuation context, generate your own Basis Report for PATH at /stock/path, or stress-test the cash flow story using our DCF calculator with PATH's own revenue and margin inputs.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
UiPath received multiple analyst price target upgrades following its worst weekly performance in 4 months, though analysts are still demanding AI revenue proof.